Neural Omega
HealthOverviewOur approach to healthMaia CorpusFor patientsMaia ClinicalFor clinicians
ResearchOverviewOur approach to researchMAR PlatformFor researchersMassa SuiteFor pharma
CompanyAboutTeam and missionMimicryThe scienceEthicsHow we workObservatoryResearch and updates
Language
Contact

Health, in the hands of those who live it.

Built for
Patients and clinicians
Principle
Consent first
Research
Flare triggers

A private ecosystem where people living with autoimmune disease and those who treat them share the complete clinical picture, and where research moves forward with their consent.

Every consultation has two people in it. Neural Omega Health is built around both: the person who lives with autoimmune disease, and the professional who treats it.

The complete picture.

Rheumatology, gastroenterology, dermatology, primary care. Four appointments in a year, and each specialist sees one part. The complete picture belongs to the person living it, and Maia brings it together.

365days with the condition

4appointments, one per specialist

Consent, for real.

Sharing a medical history should be as simple as paying with a phone. We designed it that way, for the person who shares it and for the person who receives it.

For the patient
Connecting is a gestureThey hold their phone up to their professional’s, see who they are connecting with and decide what to share.
For the professional
The appointment stays an appointmentTheir patient’s history arrives organised and ready to read, in seconds.
For both
Secure by designEvery connection is personal, confirmed by the patient, and theirs to withdraw at any time.

A private ecosystem.

Private by architecture.

Clinical information lives on the device first and works offline by design.

European by default.

Processed under the GDPR, within the European Union.1

Longitudinal by nature.

A structured record across months and years of life with the disease.

Interoperable by standard.

Designed for HL7 FHIR and the European Health Data Space.2

Portable by principle.

The record moves with the patient, and the practice moves with the clinician.

What comes before a flare.

Our health research line studies what happens before a flare. Published evidence already points to some factors, each in a specific disease and with its open question. It is our starting point.3

Measured

Looked for and not found

Not yet measured

Measured

Stopping treatment without saying so

This is the best documented item on the list. People who had stopped taking hydroxychloroquine had around three times as many flares over the following year.

The finding carries weight because it was not measured by asking, but with a blood test: it does not depend on what someone remembers, or dares to say in the consulting room.

Published figure
aOR 3.32 (95% CI 1.78–6.28) · n = 660
Associations observed in populations, each in its own condition. None predicts what will happen to an individual.
  1. 01RecordStructured, longitudinal data, shared only with consent.
  2. 02InvestigateStudies that look for patterns across people, diseases and exposures.
  3. 03ValidateOnly what shows clinical value in studies can reach practice.
The science behind it

Closing the circle.

Research begins with the person living the condition. From Maia Corpus, each patient can offer their story to the studies on MAR Platform, and what is learned returns to those who made it possible. The patient and their story, at the centre.

Maia Corpus screen on iPhone with the door to research: “Every story brings us closer to an answer”.
Voluntary
Each study is offered separately, with its purpose explained, and each person decides whether to take part.
Anonymous and aggregated
Research works with aggregated data, without anyone’s identity.

The tools of this sphere.

Maia Corpus and Maia Clinical are the tools we work with in Neural Omega Health. Each has its own website.

Take itwith you.

Clinicians, patient organisations and partners: your message goes straight to the person who can answer it.

  1. Neural Omega processes personal health data in accordance with Regulation (EU) 2016/679 (General Data Protection Regulation), within the European Union.
  2. Designed to follow the HL7 FHIR standard and the framework of Regulation (EU) 2025/327 on the European Health Data Space.
  3. Preventive and predictive medicine is a research direction of Neural Omega in health and is not part of the intended purpose of any current product. The capabilities of each product are set out on its own website.